At what age can annual health screenings be discontinued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Annual health screenings can be discontinued at age 85 for colorectal cancer screening, as recommended by the USPSTF 1, and at age 75 or older for breast cancer screening in average-risk women, as suggested by the American College of Physicians 1. The decision to stop annual screenings should be based on a person's age, overall health, life expectancy, and the specific screening test in question. Some key points to consider when deciding to discontinue screenings include:

  • Life expectancy: most preventive screenings can be discontinued when a person's life expectancy is less than 5-10 years or when the potential harms of screening outweigh the benefits.
  • Health status: for colorectal cancer screening, most guidelines suggest stopping at age 75-85, depending on health status.
  • Screening test: mammography for breast cancer screening typically continues until age 74-75 for women with average risk, while cervical cancer screening can stop at age 65 for women with adequate prior negative screening.
  • Individual values and preferences: the decision to stop screening should ultimately be personalized through shared decision-making between patients and healthcare providers, taking into account individual values, preferences, and health status, as emphasized by the American College of Physicians 1. For example, a study published in the Annals of Internal Medicine found that the average time to prevent 1 death from colorectal cancer for 1000 patients screened was 10.3 years 1, highlighting the importance of considering the time from screening to potential mortality benefit when making decisions about discontinuing screenings. Additionally, the American College of Physicians recommends discontinuing screening for breast cancer in average-risk women aged 75 years or older or in women with a life expectancy of 10 years or less 1. Overall, the decision to discontinue annual health screenings should be based on a careful consideration of the potential benefits and harms of screening, as well as individual patient factors, and should be made in consultation with a healthcare provider.

From the Research

Discontinuing Annual Health Screenings

There are no specific studies that directly answer the question of at what age annual health screenings can be discontinued. However, several studies provide guidance on screening recommendations for different types of cancer:

  • Colorectal Cancer Screening: Most guidelines recommend screening between 45 and 75 years for average-risk individuals 2.
  • Breast Cancer Screening: The US Preventive Services Task Force (USPSTF) recommends biennial screening mammography for women aged 40 to 74 years, but concludes that the evidence is insufficient to determine the balance of benefits and harms of screening mammography in women 75 years or older 3.
  • Cancer Screening in Older Adults: A study found that clinicians often consider screening cessation for older adults with limited life expectancy, but the decision-making process varies across different types of cancer screenings 4.

Key Findings

  • The age range for discontinuing annual health screenings is not explicitly stated in the provided studies.
  • Screening recommendations vary depending on the type of cancer, individual risk factors, and age.
  • The USPSTF recommends biennial screening mammography for women aged 40 to 74 years, but the evidence is insufficient to determine the balance of benefits and harms for women 75 years or older 3.
  • A systematic review found that the balance of benefits and harms of different screening intervals for breast cancer screening is still a matter of debate 5.

Screening Recommendations

  • Average-risk individuals should undergo colorectal cancer screening between 45 and 75 years 2.
  • Women aged 40 to 74 years should undergo biennial screening mammography 3.
  • The decision to discontinue annual health screenings should be made on a case-by-case basis, considering individual risk factors, age, and overall health status 4, 6, 5, 3.

Related Questions

What screening tests are recommended for a 75-year-old female at a Medicare wellness visit?
At what age does colonoscopy screening typically start for a low-risk individual, such as a 45-year-old female with no high-risk factors, specifically for average-risk (average risk) individuals?
What is the recommended cancer screening for a 35-year-old female with a history of passive smoking, whose father had lung cancer and mother had colon cancer?
What preventive screenings are recommended for a 45-year-old transgender female on Spironolactone (Aldactone), Ethinyl Estradiol, and Escitalopram (Lexapro) with a history of breast augmentation and vaginoplasty?
At what age should a 38-year-old woman with no medical history or family history of cancer start screening for colon cancer?
What is the relationship between Amlodipine (calcium channel blocker) and peripheral edema?
What laboratory studies are needed to establish care for a 49-year-old patient with hyperaldosteronism, bilateral hand pain, and Bouchard's (osteophytes) nodes?
Would a patient with hypertension on losartan (losartan potassium) 100 mg daily, now experiencing angioedema and bilateral lower extremity edema, benefit from a one-time dose of furosemide (Lasix) 40 mg?
Should a patient with angioedema and bilateral lower extremity edema, currently taking losartan (losartan potassium) 100 mg daily for hypertension, discontinue losartan and receive furosemide (Lasix) 40 mg?
What is the patient education for fibroadenoma (benign breast tumor)?
Why is a follow-up mammogram recommended for fibroadenoma (Fibroadenoma, a type of benign breast tumor)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.